Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Professor GAO Yanbin's experience in treating microvascular complications of diabetes from collateral disease
Hits 1480  Download times 826  Received:September 13, 2020  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2021.02.17
Key Words   collateral disease;diabetes;microvascular complications;GAO Yanbin
Author NameAffiliationE-mail
PANG Lei Peking University Shougang Hospital, Beijing 100144, China  
GAO Yanbin Capital Medical University, Beijing 100069, China 15911150133@163.com 
LI Buman Peking University Shougang Hospital, Beijing 100144, China  
YANG Man Peking University Shougang Hospital, Beijing 100144, China  
LI Xuemin Peking University Shougang Hospital, Beijing 100144, China  
Abstract
    Microvascular complications of diabetes affect the quality of people with diabetes's life seriously. Professor GAO Yanbin believes that collateral disease is the key to studying microvascular complications of diabetes. Qi-yin deficiency is the origin and initiation of morbidity,and phlegm and blood stasis are important inducing factors. The key of the pathogenesis is collateral obstruction. The sites of diabetic nephropathy and diabetic eye disease belong to blood collateral disease,and the clinical manifestations are consistent with the characteristics of collateral disease. Therefore,it can be treated under the guidance of the theory of collateral disease. The nature of the disease and syndrome including deficiency and excess should be distinguished in treatment. The deficiency should be blame to the deficiency of liver,spleen and kidney,and the deficiency of qi and yin,while excess should be blamed to the phlegm,wetness and stasis. The method of Tongluo must be always used during treatment.

You are the Guest visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.